Secondly, despite the experimental results indicating the key role of ACTRIIB's N-glycosylation in the proliferation of NPC cells, there was a lack of direct data from clinical samples to support the clinical relevance of these in vitro experimental results. Here, ACVR2B is linked to nasopharyngeal carcinoma.